Quantcast

Latest Anastrozole Stories

2011-06-02 12:39:00

Experimental drug may help reprogram tumor cells to respond to hormone therapy BALTIMORE, June 2, 2011 /PRNewswire-USNewswire/ -- A multicenter clinical trial led by a researcher at the University of Maryland Marlene and Stewart Greenebaum Cancer Center will evaluate a new approach to treat triple-negative breast cancer, an often-aggressive type of cancer that is more common among African-Americans and young women. The study will help researchers determine if an experimental drug,...

2011-05-10 13:40:47

In the first large trial of its kind in the United States, researchers have shown that estrogen-lowering drugs can shrink tumors and reduce mastectomy rates for patients with stage 2 or 3 breast cancer. Patients with these larger breast tumors have two options, says Matthew J. Ellis, MD, PhD, of Washington University School of Medicine in St. Louis and principal investigator of the trial conducted by the American College of Surgeons Oncology Group. "One option is to undergo mastectomy. The...

2011-04-22 00:00:29

Recent research indicates medications such as Tamoxifen or Raloxifene considerably reduce the risk of developing breast cancer in post-menopausal women. MapleLeafMeds is a reputable source for quality drugs like Tamoxifen that doctors believe may slash the risk of breast cancer by up to 43%. Vancouver, BC (PRWEB) April 21, 2011 A recent article in the Lancet Oncology by a panel of cancer experts concluded that women in the higher risk categories for breast cancer could benefit from drugs...

2011-03-14 14:17:10

Tamoxifen, taken by certain women as a preventive measure against breast cancer, saves lives and reduces medical costs. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest that the benefits of tamoxifen to prevent cancer can sufficiently compensate for its side effects in post-menopausal women under age 55 years who have an increased risk of developing breast cancer. Research has shown that...

2011-03-01 07:30:00

WALTHAM, Mass., March 1, 2011 /PRNewswire/ -- Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, announced the National Cancer Institute (NCI) will sponsor a multi-center phase 2 study of Syndax's lead product entinostat, a novel inhibitor of histone deacetylases (HDAC), and anastrozole, an aromatase inhibitor, in postmenopausal women with operable triple negative breast cancer to evaluate biomarkers and surrogates for response. The trial, to be conducted under a...

2010-12-10 07:46:44

(Ivanhoe Newswire) -- Postmenopausal women fighting a specific form of breast cancer may get some help through innovative use of two enzyme-inhibiting drugs. In hormone-receptor positive, early-stage breast cancer, estrogen causes tumor growth and must be treated with surgery.  Following surgery, patients of this form of breast cancer are therefore administered drugs which seize the production of estrogen for five years.  The drugs work by inhibiting the aromatase enzyme, which...

2010-12-09 17:13:43

Postmenopausal women who take aromatase inhibitors as a treatment for breast cancer may be at an increased risk for developing cardiovascular disease, according to the results of a meta-analysis. These data, presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, indicate that women presenting with breast cancer treatment who have risk factors for cardiovascular disease should be considered for a shorter duration of use of aromatase inhibitors. "It appears that aromatase...

2010-10-28 03:48:00

NEW YORK, Oct. 28 /PRNewswire/ -- See video from AstraZeneca at: http://www.thenewsmarket.com/CustomLink/CustomLinks.aspx?GUID=7c13a65b-0529-4b28-82e0-7ebe8b9d9f42&bhcp=1&alertid=226c94c1-b49b-45a9-b982-615158357500# Anglo-Swedish pharmaceutical company AstraZeneca announced that revenue for the third quarter declined by 2% at constant exchange rates (CER) to $7,898 million. Strong double-digit sales growth at CER for Crestor, Symbicort and Seroquel XR. Revenue in markets outside...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'